FluMist (Nasal Spray Flu Vaccine, Intranasal Influenza Vaccine) drug information, dosage, side effects, drug interactions, and warnings. FluMist, generic drug name intranasal influenza vaccine, is the first live influenza vaccine administered as a nasal spray. FluMist was approved in July 2003 by the U.S. Food and Drug Administration (FDA).

• Drugs A-Z - FluMist / Intranasal Influenza Vaccine

FluMist Nasal Spray Influenza Vaccine: Not For Immunocompromised Patients

FluMist, the nasal spray influenza vaccine, is a live attenuated vaccine; therefore it is contraindicated in immunosuppressed patients. Immunosuppressed patients should be strongly encouraged to receive vaccination against influenza using the standard injectable inactivated flu vaccines, according to the American College of Rheumatology. Read more.

Related Resources:

• Should People With Arthritis Get a Flu Shot?
• Flu Prevention
• Flu Vaccine Offers Protection
• Avoid Colds, Flu, Infection When You Take Immunosuppressive Drugs